Virginia Regulatory Town Hall
Agency
Department of Medical Assistance Services
 
GDForum ID: 644
Description of Proposed Guidance Document Changes
The purpose of this memo is to notify providers of the revisions to the Virginia Medicaid’s Preferred Drug List (PDL) Program.
 
Guidance Document(s) for this Comment Forum
 
Document ID Document Title Document in Effect Proposed Document
7079 Draft: Addition of buprenorphine/naloxone tab SL to the Virginia Common Core Formulary/Preferred Drug List n/a pdf Proposed Document
 
Contact Information
 
Name:
Meredith Lee
        Title:
Policy, Regulations, and Manuals Supervisor
 
Email:
Meredith.Lee@dmas.virginia.gov
 
Address:
600 E. Broad St., Suite 1300
 
City:
Richmond
State:  
VA
Zip:  
23219
 
Phone:
(804)371-0552
Fax:  
(804)786-1680
TDD: 
(800)343-0634
 
The Virginia Register
 

Publication Date: 8/16/2021    Volume: 37  Issue: 26
The public comment period began upon publication and lasted for 30 days. It ended on 9/15/2021.
There were no comments

Planned Effective Date:  9/16/2021 
X
ID (You can leave this blank if your agency doesn't use custom document IDs)


Title


  (a new row will be created in the table)
X
Key in part of a contact name, email address or street address and select your contact



View Guidance Documents